327 related articles for article (PubMed ID: 18602642)
1. Immunohistochemical application of an antibody specific for human CD1a to the diagnosis of canine mast cell tumour.
Yhee JY; Hong SW; Yu CH; Doster AR; Blas-Machado U; Lyoo YS; Sur JH
J Comp Pathol; 2008 Jul; 139(1):40-6. PubMed ID: 18602642
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
Fernandez NJ; West KH; Jackson ML; Kidney BA
Vet Pathol; 2005 Jul; 42(4):437-45. PubMed ID: 16006603
[TBL] [Abstract][Full Text] [Related]
3. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
Fröberg GK; Lindberg R; Ritter M; Nordlind K
J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog.
Preziosi R; Sarli G; Paltrinieri M
J Comp Pathol; 2004; 130(2-3):143-51. PubMed ID: 15003472
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
7. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
9. Comparison between May-Grünwald-Giemsa and rapid cytological stains in fine-needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications.
Sabattini S; Renzi A; Marconato L; Militerno G; Agnoli C; Barbiero L; Rigillo A; Capitani O; Tinto D; Bettini G
Vet Comp Oncol; 2018 Dec; 16(4):511-517. PubMed ID: 29961972
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin in canine mast cell tumors: decreased expression and altered subcellular localization in Grade 3 tumors.
Mackowiak II; Gentile LB; Chaible LM; Nagamine MK; Guerra JM; Mota EF; Matera JM; Mennecier G; Sanches DS; Dagli ML
Vet J; 2012 Dec; 194(3):405-11. PubMed ID: 22766308
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cyclooxygenase-2 expression in canine mast cell tumours.
Prada J; Queiroga FL; Gregório H; Pires I
J Comp Pathol; 2012 Jul; 147(1):31-6. PubMed ID: 22079567
[TBL] [Abstract][Full Text] [Related]
12. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
Meyer A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of prostaglandin E2 and vascular endothelial growth factor in canine cutaneous mast cell tumours.
Amorim RL; Pinczowski P; Neto RT; Rahal SC
Vet Comp Oncol; 2010 Mar; 8(1):23-7. PubMed ID: 20230578
[TBL] [Abstract][Full Text] [Related]
14. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
15. The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy.
Ranieri G; Passantino L; Patruno R; Passantino G; Jirillo F; Catino A; Mattioli V; Gadaleta C; Ribatti D
Oncol Rep; 2003; 10(5):1189-93. PubMed ID: 12883679
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of p27 and p21 in canine cutaneous mast cell tumors and histiocytomas.
Wu H; Hayashi T; Inoue M
Vet Pathol; 2004 May; 41(3):296-9. PubMed ID: 15133184
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous mast cell tumor with epitheliotropism in 3 dogs.
Oliveira FN; Elliott JW; Lewis BC; Mathews GG; Brown RM; Treadway CM; Langohr IM
Vet Pathol; 2013 Mar; 50(2):234-7. PubMed ID: 22700850
[TBL] [Abstract][Full Text] [Related]
18. Expression of KIT receptor in feline cutaneous mast cell tumors.
Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
[TBL] [Abstract][Full Text] [Related]
19. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.
Welle MM; Bley CR; Howard J; Rüfenacht S
Vet Dermatol; 2008 Dec; 19(6):321-39. PubMed ID: 18980632
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]